R&D Strategy
• Actual onsite observations (OR, cath labs, wards) and data analysis to examine the status quo and evaluate potential unmet needs
Our ready access to providers and key opinion leaders, as well as our expertise in both quantitative and qualitative terms, places us in a strategic position to support healthcare companies in their entry to and growth in the Japanese market.
• Actual onsite observations (OR, cath labs, wards) and data analysis to examine the status quo and evaluate potential unmet needs
• Outlining patient flows and workflows within the hospital
• Identifying stakeholder relationships and key influencers within hospitals / hospital systems
• Quantitative analysis of trends in treatment practices by patient profile, hospital type, disease type, ALOS, fees etc.
GHC also serves corporate clients who share in our vision of enhancing the value of healthcare in Japan.
Our unrivaled data-driven approach, proximity to major hospitals in Japan, and holistic understanding of Japan’s healthcare system are key elements that drive our engagements with medical device manufacturers, pharmaceutical companies, digital health companies and more.
Our ready access to providers and key opinion leaders, as well as our expertise in both quantitative and qualitative terms, places us in a strategic position to support your entry to and growth in the Japanese market.
• Japan’s healthcare overview
• National health insurance system
• Medical remuneration (shinryouhoushuu) system
• Inpatient Diagnosis Procedure Combination (DPC) system
• Impact on corporations
etc.
To help you make the most well-informed decisions on issues ranging from your R&D planning efforts to your market tracking and sales strategies, GHC will provide you with quantitative insights validated by the latest datasets, as well as qualitative insights based on direct access to KOLs and onsite studies on specific processes and workflows within the hospital.
Copyright 2022 GLOBAL HEALTH CONSULTING All rights reserved.